Digital Health News | pharmaphorum

News

BioTuring enters collaboration to enable detailed single-cel...

Research into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the process.

News

A page from Rock Health's 2021 digital health funding report

Digital health companies enabling R&D topped 2021 US investm...

According to Rock Health's annual digital health funding report, US-ba

News

Scotland backs AstraZeneca drug as first-line treatment for ...

Scotland has approved AstraZeneca’s Tagrisso (osimertinib) as a monotherapy for the for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung ca

News

Almirall and IRB Barcelona team up to tackle skin disease

Two Spanish pharma companies are joining forces to identify new oral treatments for immune-inflammatory skin diseases with high unmet medical needs.

News

Poolbeg licences candidate for broad-spectrum respiratory in...

Poolbeg Pharma has licenced a candidate for nasal immunotherapy, developed by the University of Warwick, targeting respiratory infections, such as influenza and coronavirus.

News

Clinical trial begins of lung cancer immunotherapeutic

Cancer Research UK’s Centre for Drug Development, working with the Ludwig Institute for Cancer Research and Vaccitech, has begun a phase I/IIa clinical trial of a new lung cancer vaccine.

BioTuring enters collaboration to enable detailed single-cel...

Digital health companies enabling R&D topped 2021 US investm...

Scotland backs AstraZeneca drug as first-line treatment for ...

Almirall and IRB Barcelona team up to tackle skin disease

Poolbeg licences candidate for broad-spectrum respiratory in...

Clinical trial begins of lung cancer immunotherapeutic

Senju launches first-in-class dry eye disease drug in Japan

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks